{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:06:10Z","timestamp":1716267970268},"reference-count":43,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.vaccine.2007.03.048","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:21Z","timestamp":1177153821000},"page":"4747-4754","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of combinatorial vaccines against anthrax and plague in a murine model"],"prefix":"10.1016","volume":"25","author":[{"given":"Amanda B.","family":"DuBois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy C.","family":"Freytag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Clements","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2007.03.048_bib1","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect Immun"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2007.03.048_bib2","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2007.03.048_bib3","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.vaccine.2004.10.025","article-title":"Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens","volume":"23","author":"Glynn","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2007.03.048_bib4","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1128\/IAI.73.8.5256-5261.2005","article-title":"Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens","volume":"73","author":"Glynn","year":"2005","journal-title":"Infect Immun"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.03.048_bib5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.03.048_bib6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/422694","article-title":"Induction of protective immunity against lethal anthrax challenge with a patch","volume":"190","author":"Kenney","year":"2004","journal-title":"J Infect Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2007.03.048_bib7","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1016\/j.vaccine.2004.01.007","article-title":"A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice","volume":"22","author":"Morton","year":"2004","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.048_bib8","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/IAI.66.7.3447-3448.1998","article-title":"Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis","volume":"66","author":"Singh","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.048_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.03.048_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.03.048_bib11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2007.03.048_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.048_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1086\/426865","article-title":"Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms","volume":"191","author":"Mikszta","year":"2005","journal-title":"J Infect Dis"},{"issue":"30","key":"10.1016\/j.vaccine.2007.03.048_bib14","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/S0264-410X(01)00163-3","article-title":"Vaccination against bubonic and pneumonic plague","volume":"19","author":"Titball","year":"2001","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.048_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1517\/14712598.4.6.965","article-title":"Yersinia pestis (plague) vaccines","volume":"4","author":"Titball","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"10.1016\/j.vaccine.2007.03.048_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.vaccine.2007.03.048_bib17","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: medical and public health management. Working group on civilian biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"issue":"5364","key":"10.1016\/j.vaccine.2007.03.048_bib18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.048_bib19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages","volume":"248","author":"Vitale","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.048_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/89025","article-title":"A dominant-negative therapy for anthrax","volume":"7","author":"Leppla","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.03.048_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.03.048_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb Pathog"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2007.03.048_bib23","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.03.048_bib24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"12","key":"10.1016\/j.vaccine.2007.03.048_bib25","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/nm1201-1320","article-title":"Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques","volume":"7","author":"Belyakov","year":"2001","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.048_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1128\/IAI.67.2.826-833.1999","article-title":"Effectiveness of a vaccine composed of heat-killed Candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis","volume":"67","author":"Cardenas-Freytag","year":"1999","journal-title":"Infect Immun"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.03.048_bib27","first-page":"38","article-title":"The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)","volume":"18","author":"Cheng","year":"2000","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.03.048_bib28","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/IAI.63.5.1617-1623.1995","article-title":"Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity","volume":"63","author":"Dickinson","year":"1995","journal-title":"Infect Immun"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2007.03.048_bib29","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0264-410X(02)00259-1","article-title":"B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H pylori seronegative individuals","volume":"21","author":"Losonsky","year":"2003","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2007.03.048_bib30","doi-asserted-by":"crossref","first-page":"9229","DOI":"10.1128\/JVI.75.19.9229-9238.2001","article-title":"Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2\/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs","volume":"75","author":"Yuan","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.03.048_bib31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0264-410X(97)00255-7","article-title":"LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp.","volume":"16","author":"Chong","year":"1998","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.03.048_bib32","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.75.10.4752-4760.2001","article-title":"Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA","volume":"75","author":"Gerber","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.048_bib33","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1128\/IAI.69.6.3581-3590.2001","article-title":"Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection","volume":"69","author":"Kotloff","year":"2001","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2007.03.048_bib34","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/S0264-410X(99)00447-8","article-title":"Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)","volume":"18","author":"Morris","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.03.048_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.femsim.2004.10.012","article-title":"Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine","volume":"43","author":"Griffin","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.03.048_bib36","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/0264-410X(96)00059-X","article-title":"Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults","volume":"14","author":"Gil","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.03.048_bib37","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"issue":"9043","key":"10.1016\/j.vaccine.2007.03.048_bib38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0140-6736(96)04356-5","article-title":"Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine","volume":"348","author":"Eskola","year":"1996","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2007.03.048_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/biol.1999.0204","volume":"27","author":"Gupta","year":"1999","journal-title":"Biologicals"},{"issue":"9368","key":"10.1016\/j.vaccine.2007.03.048_bib40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(03)13171-6","article-title":"Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis","volume":"361","author":"McVernon","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2007.03.048_bib41","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1086\/315119","article-title":"Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A\/hepatitis B vaccine","volume":"180","author":"Frey","year":"1999","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2007.03.048_bib42","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.03.048_bib43","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1128\/IAI.63.8.3021-3029.1995","article-title":"Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization","volume":"63","author":"Nakajima","year":"1995","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07004100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T13:32:08Z","timestamp":1587475928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07004100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":43,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0264410X07004100"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}